Invivo Therapeutics Holdings Corp (NVIV) |
|
1.23 -0.05 (-3.91%)
|
02-25 10:57 |
|
Open: |
1.3 |
Pre. Close: |
1.28 |
|
High:
|
1.31 |
Low:
|
1.21 |
|
Volume:
|
1,062,068 |
Market Cap:
|
26M |
|
|
|
|
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.403 - 1.413 |
1.413 - 1.421 |
|
Low:
|
1.229 - 1.24 |
1.24 - 1.25 |
|
Close:
|
1.263 - 1.28 |
1.28 - 1.296 |
|
Technical analysis |
as of: 2021-02-25 10:41:12 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.92  One year: 2.34 |
| Support: |
Support1: 1.07 Support2: 0.89 |
| Resistance: |
Resistance1: 1.64 Resistance2: 2.00 |
| Pivot: |
1.51  |
| Moving Average: |
MA(5): 1.35 MA(20): 1.44
MA(100): 0.96 MA(250): 1.35 |
| MACD: |
MACD(12,26): 0.06 Signal(9): 0.12 |
| Stochastic oscillator: |
%K(14,3): 20.29 %D(3): 27.39 |
| RSI: |
RSI(14): 45.69 |
| 52-week: |
High: 6.32 Low: 0.50 Change(%): -79.5 |
| Average Vol(K): |
3-Month: 607839 10-Days: 516108 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.NVIV has closed above bottom band by 10.9%. Bollinger Bands are 31.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 22 Feb 2021
InVivo Therapeutics Holdings Corp. (NVIV) Plunges 7.19% on February 22 - Equities.com
Tue, 16 Feb 2021
InVivo is up after peer-reviewed publication of study on spinal cord injury - Seeking Alpha
Tue, 16 Feb 2021
InVivo Therapeutics Announces Publication in Peer-Reviewed Journal of Neurosurgery: Spine - Yahoo Finance
Mon, 08 Feb 2021
InVivo Therapeutics Holdings Corp. (NVIV) Soars 9.86% on February 08 - Equities.com
Fri, 05 Feb 2021
InVivo Therapeutics Holdings Corp. (NVIV) Soars 2.16% on February 05 - Equities.com
Wed, 03 Feb 2021
Should Invivo Therapeutics Holdings Corp (NVIV) Stock be in Your Portfolio? - InvestorsObserver
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
